Immunology of fungal infections: Lessons learned from animal models

Current Opinion in Microbiology

Volumn 15, Issue 4, 2012, Pages 413-419

  Steele, Chad ^a   Wormley, Floyd L ^b  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AUTOIMMUNE DISEASE; EPIDEMIC; EXPERIMENTAL MODEL; FUNGUS IMMUNITY; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; MYCOSIS; NONHUMAN; PATHOGENESIS; REVIEW; TRANSGENIC ANIMAL;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; DISEASE MODELS, ANIMAL; FUNGI; HUMANS; IMMUNITY, CELLULAR; LECTINS, C-TYPE; MYCOSES; RECEPTORS, PATTERN RECOGNITION;

ANIMALIA;

EID: 84865289226     PISSN: 13695274     EISSN: 18790364     Source Type: Journal    
DOI: 10.1016/j.mib.2012.05.017     Document Type: Review

References (70)

1. Yano J., Noverr M.C., Fidel P.L. Cytokines in the host response to Candida vaginitis: identifying a role for non-classical immune mediators, S100 alarmins. Cytokine 2012, 58:118-128.
2. Takeuchi O., Akira S. Pattern recognition receptors and inflammation. Cell 2010, 140:805-820.
3. Netea M.G., Brown G.D., Kullberg B.J., Gow N.A. An integrated model of the recognition of Candida albicans by the innate immune system. Nat Rev Microbiol 2008, 6:67-78.
4. Romani L. Immunity to fungal infections. Nat Rev Immunol 2011, 11:275-288.
5. Drummond R.A., Saijo S., Iwakura Y., Brown G.D. The role of Syk/CARD9 coupled C-type lectins in antifungal immunity. Eur J Immunol 2011, 41:276-281.
6. Loures F.V., Pina A., Felonato M., Feriotti C., de Araujo E.F., Calich V.L. MyD88 signaling is required for efficient innate and adaptive immune responses to Paracoccidioides brasiliensis infection. Infect Immun 2011, 79:2470-2480.
7. Wang J.P., Lee C.K., Akalin A., Finberg R.W., Levitz S.M. Contributions of the MyD88-dependent receptors IL-18R, IL-1R, and TLR9 to host defenses following pulmonary challenge with Cryptococcus neoformans. PLoS One 2011, 6:e26232.
8. Wuthrich M., Gern B., Hung C.Y., Ersland K., Rocco N., Pick-Jacobs J., Galles K., Filutowicz H., Warner T., Evans M., et al. Vaccine-induced protection against 3 systemic mycoses endemic to North America requires Th17 cells in mice. J Clin Invest 2011, 121:554-568.
9. Hohl T.M., Rivera A., Pamer E.G. Immunity to fungi. Curr Opin Immunol 2006, 18:465-472.
10. Wuthrich M., Deepe G., Klein B. Adaptive immunity to fungi. Annu Rev Immunol 2011.
11. Netea M.G., Sutmuller R., Hermann C., Van der Graaf C.A., Van der Meer J.W., van Krieken J.H., Hartung T., Adema G., Kullberg B.J. Toll-like receptor 2 suppresses immunity against Candida albicans through induction of IL-10 and regulatory T cells. J Immunol 2004, 172:3712-3718.
12. Loures F.V., Pina A., Felonato M., Calich V.L. TLR2 is a negative regulator of Th17 cells and tissue pathology in a pulmonary model of fungal infection. J Immunol 2009, 183:1279-1290.
13. Loures F.V., Pina A., Felonato M., Araujo E.F., Leite K.R., Calich V.L. Toll-like receptor 4 signaling leads to severe fungal infection associated with enhanced proinflammatory immunity and impaired expansion of regulatory T cells. Infect Immun 2010, 78:1078-1088.
14. Drummond R.A., Brown G.D. The role of Dectin-1 in the host defence against fungal infections. Curr Opin Microbiol 2011, 14:392-399.
15. Goodridge H.S., Wolf A.J., Underhill D.M. Beta-glucan recognition by the innate immune system. Immunol Rev 2009, 230:38-50.
16. Gessner M.A., Werner J.L., Lilly L.M., Nelson M.P., Metz A.E., Dunaway C.W., Chan Y.R., Ouyang W., Brown G.D., Weaver C.T., Steele C. Dectin-1-dependent interleukin-22 contributes to early innate lung defense against Aspergillus fumigatus. Infect Immun 2012, 80:410-417.
17. 2+ flux and cytokine production in dendritic cells. J Biol Chem 2009, 284:7038-7046.
18. Goodridge H.S., Reyes C.N., Becker C.A., Katsumoto T.R., Ma J., Wolf A.J., Bose N., Chan A.S., Magee A.S., Danielson M.E., et al. Activation of the innate immune receptor Dectin-1 upon formation of a 'phagocytic synapse'. Nature 2011, 472:471-475.
19. Dennehy K.M., Ferwerda G., Faro-Trindade I., Pyz E., Willment J.A., Taylor P.R., Kerrigan A., Tsoni S.V., Gordon S., Meyer-Wentrup F., et al. Syk kinase is required for collaborative cytokine production induced through Dectin-1 and Toll-like receptors. Eur J Immunol 2008, 38:500-506.
20. Saijo S., Fujikado N., Furuta T., Chung S.H., Kotaki H., Seki K., Sudo K., Akira S., Adachi Y., Ohno N., et al. Dectin-1 is required for host defense against Pneumocystis carinii but not against Candida albicans. Nat Immunol 2007, 8:39-46.
21. Taylor P.R., Tsoni S.V., Willment J.A., Dennehy K.M., Rosas M., Findon H., Haynes K., Steele C., Botto M., Gordon S., Brown G.D. Dectin-1 is required for beta-glucan recognition and control of fungal infection. Nat Immunol 2007, 8:31-38.
22. Werner J.L., Metz A.E., Horn D., Schoeb T.R., Hewitt M.M., Schwiebert L.M., Faro-Trindade I., Brown G.D., Steele C. Requisite role for the dectin-1 beta-glucan receptor in pulmonary defense against Aspergillus fumigatus. J Immunol 2009, 182:4938-4946.
23. Steele C., Rapaka R.R., Metz A., Pop S.M., Williams D.L., Gordon S., Kolls J.K., Brown G.D. The beta-glucan receptor dectin-1 recognizes specific morphologies of Aspergillus fumigatus. PLoS Pathog 2005, 1:e42.
24. Nakamura K., Kinjo T., Saijo S., Miyazato A., Adachi Y., Ohno N., Fujita J., Kaku M., Iwakura Y., Kawakami K. Dectin-1 is not required for the host defense to Cryptococcus neoformans. Microbiol Immunol 2007, 51:1115-1119.
25. Gantner B.N., Simmons R.M., Underhill D.M. Dectin-1 mediates macrophage recognition of Candida albicans yeast but not filaments. EMBO J 2005, 24:1277-1286.
26. Hohl T.M., Van Epps H.L., Rivera A., Morgan L.A., Chen P.L., Feldmesser M., Pamer E.G. Aspergillus fumigatus triggers inflammatory responses by stage-specific beta-glucan display. PLoS Pathog 2005, 1:e30.
27. Rappleye C.A., Eissenberg L.G., Goldman W.E. Histoplasma capsulatum alpha-(1,3)-glucan blocks innate immune recognition by the beta-glucan receptor. Proc Natl Acad Sci U S A 2007, 104:1366-1370.
28. Edwards J.A., Alore E.A., Rappleye C.A. The yeast-phase virulence requirement for alpha-glucan synthase differs among Histoplasma capsulatum chemotypes. Eukaryot Cell 2011, 10:87-97.
29. Saijo S., Ikeda S., Yamabe K., Kakuta S., Ishigame H., Akitsu A., Fujikado N., Kusaka T., Kubo S., Chung S.H., et al. Dectin-2 recognition of alpha-mannans and induction of Th17 cell differentiation is essential for host defense against Candida albicans. Immunity 2010, 32:681-691.
30. Kerrigan A.M., Brown G.D. Syk-coupled C-type lectins in immunity. Trends Immunol 2011, 32:151-156.
31. Wells C.A., Salvage-Jones J.A., Li X., Hitchens K., Butcher S., Murray R.Z., Beckhouse A.G., Lo Y.L., Manzanero S., Cobbold C., et al. The macrophage-inducible C-type lectin, mincle, is an essential component of the innate immune response to Candida albicans. J Immunol 2008, 180:7404-7413.
32. LeibundGut-Landmann S., Gross O., Robinson M.J., Osorio F., Slack E.C., Tsoni S.V., Schweighoffer E., Tybulewicz V., Brown G.D., Ruland J., Reis e Sousa C. Syk- and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17. Nat Immunol 2007, 8:630-638.
33. Gross O., Gewies A., Finger K., Schafer M., Sparwasser T., Peschel C., Forster I., Ruland J. Card9 controls a non-TLR signalling pathway for innate anti-fungal immunity. Nature 2006, 442:651-656.
34. Dinarello C.A. Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol 2009, 27:519-550.
35. Gross O., Poeck H., Bscheider M., Dostert C., Hannesschlager N., Endres S., Hartmann G., Tardivel A., Schweighoffer E., Tybulewicz V., et al. Syk kinase signalling couples to the Nlrp3 inflammasome for anti-fungal host defence. Nature 2009, 459:433-436.
36. Hise A.G., Tomalka J., Ganesan S., Patel K., Hall B.A., Brown G.D., Fitzgerald K.A. An essential role for the NLRP3 inflammasome in host defense against the human fungal pathogen Candida albicans. Cell Host Microbe 2009, 5:487-497.
37. van de Veerdonk F.L., Joosten L.A., Shaw P.J., Smeekens S.P., Malireddi R.K., van der Meer J.W., Kullberg B.J., Netea M.G., Kanneganti T.D. The inflammasome drives protective Th1 and Th17 cellular responses in disseminated candidiasis. Eur J Immunol 2011, 41:2260-2268.
38. Gringhuis S.I., Kaptein T.M., Wevers B.A., Theelen B., van der Vlist M., Boekhout T., Geijtenbeek T.B. Dectin-1 is an extracellular pathogen sensor for the induction and processing of IL-1beta via a noncanonical caspase-8 inflammasome. Nat Immunol 2012, 13:246-254.
39. Cutler J.E., Deepe G.S., Klein B.S. Advances in combating fungal diseases: vaccines on the threshold. Nat Rev Microbiol 2007, 5:13-28.
40. Szymczak W.A., Deepe G.S. The CCL7-CCL2-CCR2 axis regulates IL-4 production in lungs and fungal immunity. J Immunol 2009, 183:1964-1974.
41. Muller U., Stenzel W., Kohler G., Werner C., Polte T., Hansen G., Schutze N., Straubinger R.K., Blessing M., McKenzie A.N., et al. IL-13 induces disease-promoting type 2 cytokines, alternatively activated macrophages and allergic inflammation during pulmonary infection of mice with Cryptococcus neoformans. J Immunol 2007, 179:5367-5377.
42. Zhang Y., Wang F., Tompkins K.C., McNamara A., Jain A.V., Moore B.B., Toews G.B., Huffnagle G.B., Olszewski M.A. Robust Th1 and Th17 immunity supports pulmonary clearance but cannot prevent systemic dissemination of highly virulent Cryptococcus neoformans H99. Am J Pathol 2009, 175:2489-2500.
43. Hardison S.E., Ravi S., Wozniak K.L., Young M.L., Olszewski M.A., Wormley F.L. Pulmonary infection with an interferon-gamma-producing Cryptococcus neoformans strain results in classical macrophage activation and protection. Am J Pathol 2010, 176:774-785.
44. Nelson M.P., Christmann B.S., Werner J.L., Metz A.E., Trevor J.L., Lowell C.A., Steele C. IL-33 and M2a alveolar macrophages promote lung defense against the atypical fungal pathogen Pneumocystis murina. J Immunol 2011, 186:2372-2381.
45. Martinez F.O., Helming L., Gordon S. Alternative activation of macrophages: an immunologic functional perspective. Annu Rev Immunol 2009, 27:451-483.
46. Bhatia S., Fei M., Yarlagadda M., Qi Z., Akira S., Saijo S., Iwakura Y., van Rooijen N., Gibson G.A., St Croix C.M., et al. Rapid host defense against Aspergillus fumigatus involves alveolar macrophages with a predominance of alternatively activated phenotype. PLoS One 2011, 6:e15943.
47. Gales A., Conduche A., Bernad J., Lefevre L., Olagnier D., Beraud M., Martin-Blondel G., Linas M.D., Auwerx J., Coste A., Pipy B. PPARgamma controls dectin-1 expression required for host antifungal defense against Candida albicans. PLoS Pathog 2010, 6:e1000714.
48. Conti H.R., Shen F., Nayyar N., Stocum E., Sun J.N., Lindemann M.J., Ho A.W., Hai J.H., Yu J.J., Jung J.W., et al. Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis. J Exp Med 2009, 206:299-311.
49. Huang W., Na L., Fidel P.L., Schwarzenberger P. Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice. J Infect Dis 2004, 190:624-631.
50. Rudner X.L., Happel K.I., Young E.A., Shellito J.E. Interleukin-23 (IL-23)-IL-17 cytokine axis in murine Pneumocystis carinii infection. Infect Immun 2007, 75:3055-3061.
51. Hu T., Takamoto M., Hida S., Tagawa Y., Sugane K. IFN-gamma deficiency worsen Pneumocystis pneumonia with Th17 development in nude mice. Immunol Lett 2009, 127:55-59.
52. Hardison S.E., Wozniak K.L., Kolls J.K., Wormley F.L. Interleukin-17 is not required for classical macrophage activation in a pulmonary mouse model of Cryptococcus neoformans infection. Infect Immun 2010, 78:5341-5351.
53. Wozniak K.L., Hardison S.E., Kolls J.K., Wormley F.L. Role of IL-17A on resolution of pulmonary C. neoformans infection. PLoS One 2011, 6:e17204.
54. Zelante T., De Luca A., Bonifazi P., Montagnoli C., Bozza S., Moretti S., Belladonna M.L., Vacca C., Conte C., Mosci P., et al. IL-23 and the Th17 pathway promote inflammation and impair antifungal immune resistance. Eur J Immunol 2007, 37:2695-2706.
55. Kolls J.K., McCray P.B., Chan Y.R. Cytokine-mediated regulation of antimicrobial proteins. Nat Rev Immunol 2008, 8:829-835.
56. Wolk K., Witte E., Witte K., Warszawska K., Sabat R. Biology of interleukin-22. Semin Immunopathol 2010, 32:17-31.
57. Vivier E., Raulet D.H., Moretta A., Caligiuri M.A., Zitvogel L., Lanier L.L., Yokoyama W.M., Ugolini S. Innate or adaptive immunity? The example of natural killer cells. Science 2011, 331:44-49.
58. De Luca A., Zelante T., D'Angelo C., Zagarella S., Fallarino F., Spreca A., Iannitti R.G., Bonifazi P., Renauld J.C., Bistoni F., et al. IL-22 defines a novel immune pathway of antifungal resistance. Mucosal Immunol 2010, 3:361-373.
59. Antachopoulos C. Invasive fungal infections in congenital immunodeficiencies. Clin Microbiol Infect 2010, 16:1335-1342.
60. McClelland E.E., Nicola A.M., Prados-Rosales R., Casadevall A. Ab binding alters gene expression in Cryptococcus neoformans and directly modulates fungal metabolism. J Clin Invest 2010, 120:1355-1361.
61. Brena S., Cabezas-Olcoz J., Moragues M.D., Fernandez de Larrinoa I., Dominguez A., Quindos G., Ponton J. Fungicidal monoclonal antibody C7 interferes with iron acquisition in Candida albicans. Antimicrob Agents Chemother 2011, 55:3156-3163.
62. Casadevall A., Pirofski L.A. Antibody-mediated protection through cross-reactivity introduces a fungal heresy into immunological dogma. Infect Immun 2007, 75:5074-5078.
63. Subramaniam K.S., Datta K., Quintero E., Manix C., Marks M.S., Pirofski L.A. The absence of serum IgM enhances the susceptibility of mice to pulmonary challenge with Cryptococcus neoformans. J Immunol 2010, 184:5755-5767.
64. Rapaka R.R., Ricks D.M., Alcorn J.F., Chen K., Khader S.A., Zheng M., Plevy S., Bengten E., Kolls J.K. Conserved natural IgM antibodies mediate innate and adaptive immunity against the opportunistic fungus Pneumocystis murina. J Exp Med 2010, 207:2907-2919.
65. Kling H.M., Shipley T.W., Patil S.P., Kristoff J., Bryan M., Montelaro R.C., Morris A., Norris K.A. Relationship of Pneumocystis jiroveci humoral immunity to prevention of colonization and chronic obstructive pulmonary disease in a primate model of HIV infection. Infect Immun 2010, 78:4320-4330.
66. Torosantucci A., Bromuro C., Chiani P., De Bernardis F., Berti F., Galli C., Norelli F., Bellucci C., Polonelli L., Costantino P., et al. A novel glyco-conjugate vaccine against fungal pathogens. J Exp Med 2005, 202:597-606.
67. Rachini A., Pietrella D., Lupo P., Torosantucci A., Chiani P., Bromuro C., Proietti C., Bistoni F., Cassone A., Vecchiarelli A. An anti-beta-glucan monoclonal antibody inhibits growth and capsule formation of Cryptococcus neoformans in vitro and exerts therapeutic, anticryptococcal activity in vivo. Infect Immun 2007, 75:5085-5094.
68. Bryan R.A., Jiang Z., Howell R.C., Morgenstern A., Bruchertseifer F., Casadevall A., Dadachova E. Radioimmunotherapy is more effective than antifungal treatment in experimental cryptococcal infection. J Infect Dis 2010, 202:633-637.
69. Dadachova E., Nakouzi A., Bryan R.A., Casadevall A. Ionizing radiation delivered by specific antibody is therapeutic against a fungal infection. Proc Natl Acad Sci U S A 2003, 100:10942-10947.
70. Wozniak K.L., Young M.L., Wormley F.L. Protective immunity against experimental pulmonary cryptococcosis in T cell-depleted mice. Clin Vaccine Immunol 2011, 18:717-723.